Lyell Immunopharma Ownership | Who Owns Lyell Immunopharma?
Lyell Immunopharma Ownership Summary
Lyell Immunopharma is owned by 62.57% institutional investors, 14.87% insiders, and 22.56% retail investors. Blackrock is the largest institutional shareholder, holding 5.31% of LYEL shares. T. Rowe Price Health Sciences is the top mutual fund, with 1.45% of its assets in Lyell Immunopharma shares.
LYEL Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Lyell Immunopharma | 62.57% | 14.87% | 22.56% |
| Sector | Healthcare Stocks | 486.50% | 11.08% | -397.59% |
| Industry | Biotech Stocks | 304.14% | 11.08% | -215.23% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 13.50M | 5.31% | $19.57M |
| Wuxi apptec | 7.68M | 3.02% | $11.14M |
| Arch venture management | 1.82M | 0.62% | $16.11M |
| D. e. shaw | 966.26K | 0.38% | $618.41K |
| Millennium management | 957.51K | 0.37% | $612.80K |
| Mwg management | 1.01M | 0.34% | $8.91M |
| Orland properties | 754.70K | 0.26% | $6.67M |
| Nuveen asset management | 641.17K | 0.25% | $410.35K |
| Goldman sachs group | 627.32K | 0.24% | $401.49K |
| Decheng capital | 595.47K | 0.20% | $5.26M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Wuxi apptec | 7.68M | 47.74% | $11.14M |
| Mwg management | 1.01M | 17.17% | $8.91M |
| Arch venture management | 1.82M | 5.39% | $16.11M |
| Orland properties | 754.70K | 2.83% | $6.67M |
| Takeda pharmaceutical | 41.16K | 1.86% | $363.91K |
| Decheng capital | 595.47K | 1.33% | $5.26M |
| Johnson & johnson | 41.16K | 0.11% | $368.01K |
| Rbf capital | 100.00K | 0.04% | $884.00K |
| Orbimed advisors | 51.73K | 0.01% | $457.27K |
| Susquehanna fundamental investments | 128.20K | 0.00% | $185.89K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Arch venture management | 1.82M | 5.39% | 1.82M |
| D. e. shaw | 966.26K | 0.00% | 493.64K |
| Wellington management group llp | 367.68K | 0.00% | 367.68K |
| Bnp paribas arbitrage, snc | 253.67K | 0.00% | 253.67K |
| Millennium management | 957.51K | 0.00% | 247.44K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Mwg management | 1.01M | 17.17% | -19.15M |
| Foresite capital management iv | - | - | -16.01M |
| Orland properties | 754.70K | 2.83% | -14.34M |
| Blackrock funding, inc. /de | - | - | -12.72M |
| Decheng capital | 595.47K | 1.33% | -11.31M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Arch venture management | 1.82M | 5.39% | 1.82M | $16.11M |
| Wellington management group llp | 367.68K | 0.00% | 367.68K | $533.13K |
| Bnp paribas arbitrage, snc | 253.67K | 0.00% | 253.67K | $162.35K |
| Rbf capital | 100.00K | 0.04% | 100.00K | $884.00K |
| Orbimed advisors | 51.73K | 0.01% | 51.73K | $457.27K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -34.00 |
| Rothschild investment | -50.00 |
| True wealth design | -60.00 |
| Srs capital advisors | -95.00 |
| Eversource wealth advisors | -106.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 68 | -39.82% | 9,256,423 | -93.92% | 62 | 939.01% | 12 | -68.42% | 55 | 52.78% |
| Mar 31, 2025 | 112 | 8.74% | 152,309,719 | 1.35% | 51 | 1.50% | 38 | -26.92% | 37 | 48.00% |
| Dec 31, 2024 | 97 | -17.09% | 146,305,210 | 13.92% | 57 | 2.27% | 47 | -6.00% | 24 | -22.58% |
| Sep 30, 2024 | 117 | 0.86% | 128,424,945 | -3.67% | 50 | 1.82% | 51 | 4.08% | 31 | -27.91% |
| Jun 30, 2024 | 116 | -5.69% | 133,324,052 | 0.44% | 52 | 1.91% | 49 | -14.04% | 43 | -2.27% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| T. Rowe Price Health Sciences | 214.56K | 1.45% | -8.08K |
| Vanguard Total Stock Mkt Idx Inv | 276.12K | 1.44% | -6.10K |
| iShares Russell 2000 ETF | 4.13M | 1.39% | - |
| Biotech Growth Ord | 2.88M | 0.99% | - |
| Vanguard Small Cap Index | 2.24M | 0.87% | 5.37K |
| iShares Russell 2000 Value ETF | 1.47M | 0.49% | - |
| Vanguard Small Cap Growth Index Inv | 1.25M | 0.49% | -5.54K |
| Vanguard Institutional Extnd Mkt Idx Tr | 91.69K | 0.48% | -37.12K |
| Fidelity Small Cap Index | 1.63M | 0.44% | - |
| State St Russell Sm/Mid Cp® Indx NL Cl C | 1.18M | 0.40% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 21, 2025 | Seely Lynn | President and CEO | Sell | $76.52K |
| Aug 21, 2025 | Hill Stephen J. | Chief Operating Officer | Sell | $10.59K |
| Aug 21, 2025 | Newton Charles W. | Chief Financial Officer | Sell | $15.32K |
| Aug 21, 2025 | Lee Gary K. | Chief Scientific Officer | Sell | $15.32K |
| Aug 11, 2025 | Seely Lynn | President and CEO | Sell | $4.12K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | 12 |
| 2025 Q2 | - | - |
| 2025 Q1 | 5 | - |
| 2024 Q4 | - | - |
| 2023 Q4 | - | - |
LYEL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools